Mode
Text Size
Log in / Sign up

Case Report Describes Non-Secretory Multiple Myeloma With Eosinophilia in a 56-Year-Old ManBack Pain and High White Cells: A Hidden Cancer Case

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider bone marrow biopsy for eosinophilia with suspected myeloma, noting evidence is limited to single case reports.

This publication is a case report involving a 56-year-old man. The scope focuses on the clinical presentation and diagnostic confirmation of non-secretory multiple myeloma in the context of marked eosinophilia. The authors document the specific pathological findings required to establish the diagnosis in this complex presentation.

The primary outcome involved confirming the diagnosis through bone marrow biopsy. Immunohistochemistry and flow cytometry identified clonal plasma cells accounting for 6.1% of nucleated cells. No specific intervention or comparator was utilized in this observational account. Follow-up duration and safety outcomes were not reported in the available data.

The authors acknowledge significant limitations regarding the generalizability of these findings. Specifically, there is limited literature on multiple myeloma-associated eosinophilia. This scarcity restricts the ability to draw broader conclusions about the association or management strategies for this rare presentation. The sample size of 1 limits statistical inference entirely.

Practice relevance centers on the diagnostic challenge posed by the coexistence of marked eosinophilia and non-secretory multiple myeloma. Clinicians should recognize this potential overlap when evaluating similar hematologic profiles. However, the single-case nature precludes definitive recommendations for routine care or screening protocols.

Given the observational nature and lack of comparative data, this report serves primarily as a descriptive reference. It underscores the necessity of thorough bone marrow evaluation when eosinophilia and myeloma features appear concurrently. Further research is required to clarify the pathophysiology and optimal management approaches for this specific clinical scenario.

A 56-year-old man walked into the hospital with a problem he’d had for over ten years: nagging back pain. But this time, it was different. In just ten days, the pain became severe and spread through his body. He had also lost weight without trying. Doctors knew something was wrong, but the cause wasn’t clear.

This is a story about a hidden disease that can mimic other problems. It shows why doctors must look deeper when symptoms don’t add up.

Multiple myeloma is a cancer of plasma cells, a type of white blood cell that helps fight infection. It usually affects older adults and can cause bone pain, fatigue, and kidney problems. It’s not rare among blood cancers, but it can be tricky to spot early.

The most common way doctors find it is by detecting a special protein in the blood or urine. This protein is made by the cancer cells. But in about 1% of cases, called non-secretory myeloma, the cancer cells don’t make this protein. This makes the disease much harder to diagnose.

The Old Way vs. The New Way

For years, doctors relied heavily on blood and urine tests to find myeloma. If those tests were negative, they often looked elsewhere for the cause of a patient’s symptoms. This case challenges that approach.

Here’s the twist: even when standard protein tests are normal, the cancer can still be there. It just requires looking in a different place—the bone marrow.

Think of myeloma cells like a factory that has stopped shipping its product. The factory (the cancer cell) is still running, but the product (the protein) isn’t being released into the bloodstream. So, a blood test won’t find it.

Doctors need to visit the factory directly. A bone marrow biopsy is like sending an inspector into the factory to see what’s happening on the inside. This is where they found the cancer cells in this patient.

This report details the case of a 56-year-old man admitted to the hospital. Doctors ran a full workup, including blood tests, imaging scans, and a bone marrow biopsy. They also reviewed medical literature on similar cases to understand the bigger picture.

The patient’s blood tests showed some clues, but not the classic ones for myeloma. He had a high count of a specific white blood cell called an eosinophil, a low platelet count, and high inflammatory markers. Imaging scans revealed multiple holes in his bones, a classic sign of myeloma.

But the standard myeloma protein tests were all negative.

The key came from the bone marrow. It showed a high number of eosinophils and, more importantly, a small population of cancerous plasma cells. Genetic testing of these cells revealed specific abnormalities linked to myeloma.

After ruling out other causes of high eosinophils, the doctors made the diagnosis: non-secretory multiple myeloma with eosinophilia.

This is a reminder that a negative protein test does not always rule out myeloma.

This case highlights a major diagnostic challenge. When a patient has bone lesions and high eosinophils but negative protein tests, doctors might suspect other diseases. This report emphasizes that myeloma should still be on the list. It shows the importance of not stopping the investigation when the first set of tests comes back negative.

If you or a loved one has persistent bone pain, weight loss, and unusual blood test results, this story is a reminder to advocate for a thorough evaluation. A bone marrow biopsy may be necessary to get a clear answer, especially if standard tests are inconclusive.

This diagnosis is not made from a simple blood draw. It requires a specialist and more invasive testing.

This is a single case report. It shows one example of how this disease can present, but it doesn’t prove this is common. Every patient is different, and more research is needed to understand how often this happens.

Doctors will use this case to help recognize similar patients in the future. The next step is to study more cases to see how often non-secretory myeloma is missed when eosinophilia is present. This could lead to updated guidelines for diagnosing tricky cases like this one.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
We report a rare case of non-secretory multiple myeloma (NSMM) presenting with marked eosinophilia and considerable diagnostic difficulty. A 56-year-old man was admitted with recurrent low back pain of more than 10 years’ duration that had rapidly worsened over the preceding 10 days, accompanied by diffuse pain and weight loss. Laboratory evaluation showed persistent eosinophilia, thrombocytopenia, elevated lactate dehydrogenase, and increased inflammatory markers. Imaging revealed multifocal osteolytic lesions involving the skull, vertebrae, ribs, and pelvis. However, serum and urine immunofixation electrophoresis were negative, qualitative urine Bence-Jones protein testing was negative, and repeated serum free light chain testing showed a normal κ/λ ratio, making the diagnosis particularly challenging. Bone marrow aspirate showed marked eosinophilia, and flow cytometry identified clonal plasma cells accounting for 6.1% of nucleated cells. Bone marrow biopsy with immunohistochemistry confirmed a plasma-cell neoplasm, while myeloma fluorescence in situ hybridization (FISH) revealed 1q21 gain/amplification together with chromosome 13-related abnormalities, including RB1 deletion and D13S319 abnormality. After exclusion of secondary and primary/clonal eosinophilic disorders, the patient was diagnosed with NSMM with eosinophilia. This case highlights the diagnostic challenge posed by the coexistence of marked eosinophilia and NSMM, which obscured the underlying plasma-cell malignancy despite repeatedly negative monoclonal protein studies. We also reviewed the limited literature on MM-associated eosinophilia to underscore the importance of integrating bone marrow findings, imaging, and cytogenetic evaluation in atypical cases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.